(1'S,2'R,3'S,4'R,5'S)-4-(6-AMINO-9H-PURIN-9-YL)-1-[PHOSPHORYLOXYMETHYL]-BICYCLO-[3.1.0]-HEXANE-2,3-DIOL
Compound with spectra: 1 NMR
![(1'S,2'R,3'S,4'R,5'S)-4-(6-AMINO-9H-PURIN-9-YL)-1-[PHOSPHORYLOXYMETHYL]-BICYCLO-[3.1.0]-HEXANE-2,3-DIOL](/api/compound/9RRI8ocairA.png?ph=true&h=300&w=458 "(1'S,2'R,3'S,4'R,5'S)-4-(6-AMINO-9H-PURIN-9-YL)-1-[PHOSPHORYLOXYMETHYL]-BICYCLO-[3.1.0]-HEXANE-2,3-DIOL")
| SpectraBase Compound ID | 9RRI8ocairA |
|---|---|
| InChI | InChI=1S/C12H16N5O6P/c13-10-6-11(15-3-14-10)17(4-16-6)7-5-1-12(5,9(19)8(7)18)2-23-24(20,21)22/h3-5,7-9,18-19H,1-2H2,(H2,13,14,15)(H2,20,21,22)/t5-,7-,8+,9+,12+/m1/s1 |
| InChIKey | KNZKZWWUSXDLFM-PHPBVZTRSA-N |
| Mol Weight | 357.26 g/mol |
| Molecular Formula | C12H16N5O6P |
| Exact Mass | 357.08382 g/mol |
| Enantiomer InChIKey | KNZKZWWUSXDLFM-AKAASKOMSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
(1'-S,2'-R,3'-S,4'-R,5'-S)-4'-(6-AMINOPURIN-9-YL)-2',3'-(DIHYDROXY)-1'-(PHOSPHONOMETHYLENE)-BICYCLO-[3.1.0]-HEXANE
(1'-S,2'-R,3'-S,4'-R,5'-S)-4'-(6-AMINOPURIN-9-YL)-2',3'-(DIHYDROXY)-1'-(PHOSPHONOETHENYL)-BICYCLO-[3.1.0]-HEXANE
(1'-S,2'-R,3'-S,4'-R,5'-S)-4'-(6-AMINOPURIN-9-YL)-2',3'-(DIHYDROXY)-1'-[(E)-PHOSPHONOETHENYL]-BICYCLO-[3.1.0]-HEXANE
(1R,2S,4S,5S)-PHOPHORIC-ACID-MONO-[4-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-1-HYDROXYMETHYL-BICYCLO-[3.1.0]-HEX-2-YL]-ESTER
(1R,2S,4S,5S)-PHOPHORIC-ACID-MONO-[4-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-HYDROXY-BICYCLO-[3.1.0]-HEX-1-YL-METHYL]-ESTER
1,3-Dioxolo[3,4]cyclopenta[1,2-d][1,3]dioxin, 9H-purin-6-amine deriv.
2',3'-DI-O-ACETYL-5-DEOXY-5-METHYLTHIO-5-FLUOROADENOSINE
2',3'-DI-O-ACETYL-5'-S-FLUORO-5'-S-METHYL-5'-THIOADENOSINE
9-(5-S-Methyl-5-thio-5-fluoro-2,3-di-O-acetyl-.beta.-D-arabinofuranosyl)adenine
ADENOSINE-5'-(4-DEOXY-ALPHA-L-GULO-HEPTOPYRANOSYL_DIPHOSPHATE)-BIS-(TRIETHYLAMINE)-SALT
| Title | Journal or Book | Year |
|---|---|---|
| Methanocarba Modification of Uracil and Adenine Nucleotides: High Potency of Northern Ring Conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but Not P2Y6 Receptors | Journal of Medicinal Chemistry | 2001 |